DARPA + Ferocity Biodefense Summit and Reception at JP Morgan 2026

​Join DARPA and Ferocity Capital for a distinguished Biodefense Summit and Reception during the 2026 JPM Healthcare Conference.

​This high-level gathering will convene investors, CEOs, founders, leading researchers, and policymakers to explore the future of biodefense and biosecurity innovation.

​Highlights include:

• ​Keynote from Dr. Michael Koeris, Director of DARPA’s Biological Technology Office, on new office priorities and DARPA’s commercialization strategy

• ​Expert panel sessions on:

  • ​Early-stage funding and exit trends in biosecurity

  • ​Strategic partnerships with the U.S. Department of Defense for growth

  • ​Regulatory pathways for innovation

  • ​Cutting-edge developments in biodefense

​The evening will conclude with a networking reception to continue discussions in an informal setting.

​Registration is by invitation only. All invitations must be approved by DARPA. Venue capacity is limited, so early confirmation is encouraged.

​We look forward to welcoming you to this important event.

Ferocity Capital is a venture capital fund established in 2018 that invests in cybersecurity and scientific discovery. We back ambitious founders and research spin-outs, validating disruptive technologies with prospective customers before we invest.
https://www.ferocitycap.com/